Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial fi

Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds. In a first-of-its-kind clinical trial, U.S.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly less agitation than people who received a placebo.

• Ponto de atenção: cannabis.
• Ponto de atenção: derived.
• Ponto de atenção: treatment.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.